[PL]Reconsidering pharmacy and pharmaceutical science for the future
○Itsuko Ishii1(1. Div. Pharm., Chiba Univ. Hosp.)
Search Criteria
Keywords :
Year :
2020 - 2026
Search across all events. Up to 10,000 search results will be displayed.
-
Search Criteria
| Keywords : | |
|---|---|
| Year : | 2020 - 2026 |
Search across all events. Up to 10,000 search results will be displayed.
-
Search Results(10,000+)
Due to the large number of search results, only up to 10,000 are displayed. If you cannot find the results you need, please refine your search by specifying additional conditions.
[SL01]Modulating Ferroptosis for Disease Prevention
○Marcus Conrad1,2(1. Helmholtz Zentrum München, Institute of Metabolism and Cell Death, Neuherberg, Germany, 2. Translational Redox Biology, Technical University of Munich (TUM), TUM Natural School of Sciences, Germany)
[SL02]Cellular stress: sensing mechanisms and diseases
○Hidenori Ichijo1(1. Adv. Res. Dept., Ins. Sci. Tokyo)
[SL03]Data Science Tools for Synthetic Methods Development
○Abigail G. Doyle1(1. University of California, Los Angeles)
[SL04]Studies on catalytic asymmetric synthesis for 40 years
○Masakatsu Shibasaki1(1. Institute of Microbial Chemistry)
[SL05]Glia and Pain: Application to Green-Pharma Research
○Kazuhide Inoue1(1. Inst. Adv. Study, Kyushu Univ.)
[SL06]Pharmacological Basis of Gα12-Mediated Metabolic Regulation
○Sang Geon Kim1,2,3(1. Coll. Pharm., Dongguk Univ., 2. Grad. Sch. Med., Dongguk Univ., 3. Biomed. Res. Plan. & Strat., Dongguk Univ. Med. Cent.)
[AL05]Lipid metabolism related to atherosclerosis: characterization of oxidized LDL in vivo and regulation of intracellular lipid droplets.
○Hiroyuki Itabe1(1. Showa Univ. Sch. of Pharm.)
[AL01]Exploratory study on functional expansion of brain circuits
○Yuji Ikegaya1(1. Graduate School of Pharmaceutical Sciences, The University of Tokyo)
[AL02]Development of targeted protein degradation and SNIPER compounds
○Mikihiko Naito1(1. Grad. Sch. Pharm. Sci., Univ. Tokyo)
[AL20]Pharmaceutical health science: history, indispensability, and the development of pharmaceutical professionals for its education and practice
○Toshiyuki Kaji1(1. Tokyo Univ. of Sci.)
[AL21]My journey in developing a fascination for the history and sciences of poisons
○Shinji Funayama1,2(1. Nihon Pharm. Univ., 2. The Jap. Soc. for the Hist. of Pharm.)
[AL22]Discovery of ensitrelvir, a COVID-19 treatment targeting 3CL protease
○Yuki Tachibana1, Yuto Unoh1, Shota Uehara1, Haruaki Nobori1, Teruhisa Kato1(1. SHIONOGI & CO., LTD.)
[AL23]Creation of trastuzumab deruxtecan, a novel cancer treatment drug, by innovating new-generation antibody-drug conjugate technology, DXd-ADC
Toshinori Agatsuma1, ○Yuki Abe1, Hiroyuki Naito1, Takashi Nakada1, Yusuke Ogitani1(1. Daiichi Sankyo)
[AL10]Development of catalyst systems enabling sp3 C-H functionalization reactions
○Harunobu Mitsunuma1(1. Grad. Sch. Pharm. Sci., the Univ. of Tokyo)
[AL18]Development of a data-driven prediction model of adverse drug reactions using large-scale medical information and machine learning
○Kaori Ambe1(1. Graduate School of Pharmaceutical Sciences, Nagoya City University)
[AL11]Establishment of quality assessment platform for pharmaceutical formulations based on the molecular-level characterization
○Keisuke Ueda1(1. Graduate School of Pharmaceutical Sciences, Chiba University)
[AL06]Elucidation of pathogenesis and development of fundamental therapeutics of intractable diseases based on stem cell research
○Eiichi Hinoi1(1. Gifu Pharmaceutical University)
[AL07]Development of targeted drug delivery system to bone or kidney using amino acid modification
○Hidemasa Katsumi1(1. Faculty Pharm., Osaka Ohtani Univ.)
[AL03]Natural product-prompted chemical biology research toward drug discovery
○Hideaki Kakeya1(1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
[AL04]Biosynthetic study on natural products for innovative drug discovery
○Kenji Watanabe1(1. Dept. Pharm. Sci.)
[AL08]Development of frontier artificial nucleoside derivatives utilizing fine molecular recognition of nucleic acids and deployment of drug discovery
○Yosuke Taniguchi1(1. Faculty of Pharmaceutical Sciences at Okayama University)
[AL09]Development of cell-penetrating peptides and their application to DDS
○Makoto Oba1(1. Grad. Sch. Med. Sci., Kyoto Prefectural Univ. of Medicine)
[AL12]Roles of Temperature and Reactive Oxygen Species in Physiology
○Takahito Miyake1(1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
[AL24]Advancing drug interaction management based on the pharmacokinetic drug interaction significance classification system (PISCS)
○Yoshiyuki Ohno1(1. Department of Pharmacy, The University of Tokyo Hospital)
[AL13]Development of Functional Artificial Nucleic Acid Materials and Ligand Conjugate Synthesis for Pharmaceutical Applications
○Osawa Takashi1(1. Grad. Sch. Pharm. Sci., Osaka Univ.)
[AL14]Functional analysis and inhibitor discovery of 2OGX based on their 3D-structures.
○Yu Nakashima1(1. Inst. of Nat. Med., Univ. of Toyama)
[AL15]Development of biological-event manipulator triggered by molecule-light interaction
○Naoya Ieda1(1. Grad. Sch. Pharm. Sci., Hokkaido Univ.)
[AL16]Exploration and biocatalytic applications of specialized enzymes in natural product biosynthesis
○Kenichi Matsuda1(1. Grad. Sch. Pharm. Sci., Hokkaido Univ.)
[AL19]Synthesis of multisubstituted compounds using catalyst-controlled site-selective reactions
○Miyuki Yamaguchi1(1. Univ. of Shizuoka)
[AL17]Efficient total synthesis of densely functionalized natural products by new complexity-generating strategy
○Koichi Hagiwara1(1. Grad. Sch. Pharm. Sci., U. Tokyo)
[IS01-1]Epigenetic biomarkers for alcohol-related chronic diseases
○Mihi Yang1,2(1. Dept. of Toxicology, College of Pharmacy, Sookmyung Women's Univ., 2. Goodbeing Center Co., Ltd.)
[IS01-2]Implications of metabolic dysfunction associated with medications with high dependency potentials
○Yeo Jin Choi1,2,3, Yujin Kim2,3, Yu Jin Sohn1(1. Department of Pharmacy, Kyung Hee University, 2. Department of Regulatory Science, Kyung Hee University, 3. Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University)
[IS01-3]Oxidation of fenamic acid NSAIDs and related environmental contaminants – linkagesthrough reactive metabolites and radicals
○Arno G. Siraki1,2, Newton H Tran1, Steven Lockhart1, Lusine Tonoyan1,2, Othman Eldalal1, Huan Liu1, Kirtypal Singh1(1. University of Alberta, College of Health Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, 2. iARMA Lab)
[IS01-4]The early innate immune response to drugs may provide biomarkers of idiosyncratic drug reaction risk
○Jack Uetrecht1(1. University of Toronto)
[IS01-5]Transitioning from local wisdom and downscaling analysis to innovative approaches in green pharmaceutical analysis
○Chalermpong Saenjum1, Sutasinee Apichai1,2, Thanawat Pattanandecha1,2, Kanokwan Kiwfo2, Siripat Suteerapataranon3, Fumihiko Ogata4, Naohito Kawasaki4, Kate Grudpan3(1. Fac. Pharm., Chiang Mai Univ., 2. Office Res. Admin., Chiang Mai Univ., 3. Fac. Sci., Chiang Mai Univ., 4. Fac. Pharm., Kindai Univ.)
[IS01-6]Recent advances in hexavalent chromium removal from aqueous solutions by adsorption technique using layered double hydroxides
○Fumihiko Ogata1(1. Fac. Pharm., Kindai Univ.)
[OS01-1]SENTAN-Q: Creating a university where women can thrive
○Kaoru Tamada1,2(1. IMCE Kyushu Univ., 2. Office for the Promotion of Gender Equality, Kyushu University)
[OS01-2]Diversity from the perspective of a pharmaceutical science lab PI
○Makoto Tsuda1(1. Grad Sch Pharm Sci, Kyushu Univ)
[OS01-3]The Current State of Diversity in the Healthcare Workplace
○Hideyuki Terazono1,2(1. Kagoshima Univ. Hosp., 2. Kagoshima Univ. Med. Dent. Sci.)
[OS02-1]Nagai Memorial Pharmaceutical Research Encouragement Support Project : Introduction
○Yoshinobu Takakura1(1. Hakubi Center Adv Res, Kyoto Univ)
[OS02-2]Career and research initiatives of pharmacists supporting community medicine and pharmaceutical education
○Yuya Futagi1(1. Hosp. Pharm., Kanazawa Univ.)
[OS02-3]The Nagai Memorial Pharmaceutical Research Encouragement Support enables me to expand my career horizons.
○Yuki Kanase1(1. Kyoto Pharmaceutical University)
[OS02-4]Rich experience from Nagai Memorial Research Scholarship Support
○Naruki Konishi1(1. Kitasato Univ. Sch. of Pharm.)
[OS02-5]My studies in pharmaceutical sciences promoted by the nagai memorial pharmaceutical research encouragement support in my career
○Kazuaki Takahashi1(1. Grad. Sch. Hort., Chiba Univ.)
[OS02-6]For the Future of Pharmaceutical Sciences
○Itsuko Ishii1(1. Chiba University Hospital)
[SS01-1]Development of reactive species and catalysts for selective organic reactions using machine learning
○Makoto Yasuda1, Yuya Tsutsui1, Yoshihiro Nishimoto1, Akihito Konishi1, Yusei Yoshida2, Kazuhiro Takeda2(1. Grad. Sch. Eng., Osaka Univ., 2. Grad. Sch. Integrated Sci. Tech., Shizuoka Univ.)
[SS01-2]Machine learning applied to catalyst design and yield prediction in organic chemistry
○Kazuhiro Takeda1, Makoto Yasuda2, Naoya Ohtsuka3,4, Toshiyasu Suzuki3, Norie Momiyama3,4(1. Grad. Sch. Integrated Sci. Tech., Shizuoka Univ., 2. Grad. Sch. Eng., Osaka Univ., 3. IMS, 4. SOKENDAI)
[SS01-3]Machine Learning-Assisted development of visible light-induced fluoroalkyaltion
○Tomoko Yajima1(1. Fac. Core Res., Ochanomizu Univ.)
[SS01-4]Flow integrated synthesis of strained molecules toward digital optimization
○Kiyosei Takasu1, Aki Kohyama1, Yousuke Yamaoka1(1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
10,000 results ( 1 - 50 )
- 1
- ...